15 results
DEFR14A
ARCT
Arcturus Therapeutics Holdings Inc
12 May 22
Revised proxy
5:00pm
, as applicable.
Our Board has also determined that Mr. Barlow qualifies as an audit committee financial expert within the meaning of the applicable rules
10-K
EX-10.1
l96c0 jl1a63sxz
16 Mar 20
Annual report
11:09am
DEF 14A
jkh4bkiqx5p78m
1 Oct 19
Definitive proxy
6:07am
8-K
EX-10.2
ybxrrfmt hbekqd9i
20 Jun 19
License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases
6:06am
424B3
k5nlqdz svu
12 Apr 19
Prospectus supplement
4:39pm
S-4/A
2q1q7o8b uy
11 Apr 19
Registration of securities issued in business combination transactions (amended)
5:26pm
S-4
qlktk5mz3g4ez
15 Mar 19
Registration of securities issued in business combination transactions
9:35pm
- Prev
- 1
- Next